A new tablet that combines albendazole and ivermectin ... the EDCTP-funded STOP consortium tested a fixed-dose co-formulation (FDC) of albendazole and ivermectin in the ALIVE trial, which took ...
This attribute enhances the favorable pharmacokinetic profile of the combination tablet. The FDC tablet has been shown to be both safe and well tolerated, offering comprehensive glycemic control ...